chr5-132679140-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000589.4(IL4):​c.184-574G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.337 in 152,072 control chromosomes in the GnomAD database, including 12,080 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 12080 hom., cov: 32)

Consequence

IL4
NM_000589.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.139

Publications

37 publications found
Variant links:
Genes affected
IL4 (HGNC:6014): (interleukin 4) The protein encoded by this gene is a pleiotropic cytokine produced by activated T cells. This cytokine is a ligand for interleukin 4 receptor. The interleukin 4 receptor also binds to IL13, which may contribute to many overlapping functions of this cytokine and IL13. STAT6, a signal transducer and activator of transcription, has been shown to play a central role in mediating the immune regulatory signal of this cytokine. This gene, IL3, IL5, IL13, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL13. This gene, IL13 and IL5 are found to be regulated coordinately by several long-range regulatory elements in an over 120 kilobase range on the chromosome. IL4 is considered an important cytokine for tissue repair, counterbalancing the effects of proinflammatory type 1 cytokines, however, it also promotes allergic airway inflammation. Moreover, IL-4, a type 2 cytokine, mediates and regulates a variety of human host responses such as allergic, anti-parasitic, wound healing, and acute inflammation. This cytokine has been reported to promote resolution of neutrophil-mediated acute lung injury. In an allergic response, IL-4 has an essential role in the production of allergen-specific immunoglobin (Ig) E. This pro-inflammatory cytokine has been observed to be increased in COVID-19 (Coronavirus disease 2019) patients, but is not necessarily associated with severe COVID-19 pathology. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.753 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000589.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL4
NM_000589.4
MANE Select
c.184-574G>A
intron
N/ANP_000580.1
LOC105379176
NR_134248.1
n.1153C>T
non_coding_transcript_exon
Exon 2 of 2
IL4
NM_172348.3
c.136-574G>A
intron
N/ANP_758858.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL4
ENST00000231449.7
TSL:1 MANE Select
c.184-574G>A
intron
N/AENSP00000231449.2
IL4
ENST00000350025.2
TSL:1
c.136-574G>A
intron
N/AENSP00000325190.3
IL4
ENST00000622422.1
TSL:1
c.285-574G>A
intron
N/AENSP00000480581.1

Frequencies

GnomAD3 genomes
AF:
0.337
AC:
51164
AN:
151954
Hom.:
12051
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.608
Gnomad AMI
AF:
0.0165
Gnomad AMR
AF:
0.339
Gnomad ASJ
AF:
0.206
Gnomad EAS
AF:
0.774
Gnomad SAS
AF:
0.194
Gnomad FIN
AF:
0.363
Gnomad MID
AF:
0.174
Gnomad NFE
AF:
0.157
Gnomad OTH
AF:
0.291
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.337
AC:
51250
AN:
152072
Hom.:
12080
Cov.:
32
AF XY:
0.344
AC XY:
25563
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.608
AC:
25218
AN:
41460
American (AMR)
AF:
0.339
AC:
5187
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.206
AC:
716
AN:
3470
East Asian (EAS)
AF:
0.773
AC:
3982
AN:
5152
South Asian (SAS)
AF:
0.193
AC:
932
AN:
4820
European-Finnish (FIN)
AF:
0.363
AC:
3847
AN:
10586
Middle Eastern (MID)
AF:
0.184
AC:
54
AN:
294
European-Non Finnish (NFE)
AF:
0.157
AC:
10679
AN:
67962
Other (OTH)
AF:
0.294
AC:
620
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1418
2837
4255
5674
7092
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.191
Hom.:
1510
Bravo
AF:
0.355
Asia WGS
AF:
0.483
AC:
1679
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.82
DANN
Benign
0.44
PhyloP100
0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2243274; hg19: chr5-132014832; API